ACTIVE

PHARMAEXPRESS

Financial year 2025 · Closed on 31/12/2025

Net result162,6 k €-48,5 %over 1 year
Revenue428,7 k €-45,2 %over 1 year
Equity576,3 k €+39,3 %over 1 year
Workforce2,0 ETP-45,9 %over 1 year

Identity

Source · BCE/KBO

PHARMAEXPRESS is a Private limited company incorporated in 2020. Its main activity is: Computer consultancy activities. Its registered office is in Thimister-Clermont. It employs on average 2,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0743.800.651
Incorporation
18/02/2020
Legal form
Private limited company
Registered office
Rue de l'Avenir 12
4890 Thimister-Clermont · WallonieSee on map
Contributed capital
500 000,00 €
Latest accounts
31/12/2025
Average workforce
2,0 ETP
Contacts
2 public details availableLog in to view
Signals
ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 6 filings

Trend over 6 financial years

20252024202320222021
Income statement
Revenue428,7 k €781,8 k €816,7 k €1,9 M €970,9 k €
EBITDA188,9 k €323,5 k €-79,8 k €-8,2 k €-123 k €
Operating result188,9 k €319 k €-132,2 k €-58,7 k €-173,4 k €
Net result162,6 k €315,7 k €-120,9 k €-56,5 k €-173,6 k €
Balance sheet
Equity576,3 k €413,7 k €97,9 k €218,9 k €275,3 k €
Total assets582,2 k €554,6 k €211,6 k €382,4 k €565,5 k €
Cash459,8 €204 €1,5 k €22,6 k €3,5 k €
Debts5,9 k €140,9 k €113,6 k €163,5 k €290,2 k €
Other
Workforce2,0 ETP3,7 ETP1,4 ETP0,8 ETP1,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 3 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT0402.307.894Represented by HELENE GORRIA
Directorsince 14/02/2020
PIERRE LAFLEUR
Directorsince 14/02/2020

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
JACQUES GERCKENS
Director01/04/2021 → 2022 accounts
MARC BREYER
Director14/02/2020 → 2022 accounts
SINOPLE0479.432.396Represented by LAURENT KINET
Managing director14/02/2020 → 2020 accounts

Other companies at this address

Rue de l'Avenir 12 4890 Thimister-Clermont
CompanyCBE no.
GENERATION 2000● Active
0432.862.104
0402.353.129
0859.769.297
0420.259.329
0402.307.894
PHARMA FUTUR● Active
0787.394.827
SANTIS PHARMA● Active
0421.562.592
V-IMMO● Active
0461.767.213

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date28/04/202619/05/202514/05/202425/04/202329/04/202211/05/2021
General meeting27/04/202628/04/202522/04/202424/04/202325/04/202226/04/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 6 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202527/04/202628/04/2026FrenchPDF
Abridged model31/12/202428/04/202519/05/2025FrenchPDF
Abridged model31/12/202322/04/202414/05/2024FrenchPDF
Abridged model31/12/202224/04/202325/04/2023FrenchPDF
Abridged model31/12/202125/04/202229/04/2022FrenchPDF
Abridged model31/12/202026/04/202111/05/2021FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 3 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT0402.307.894Represented by HELENE GORRIA
Directorsince 14/02/2020
PIERRE LAFLEUR
Directorsince 14/02/2020

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
JACQUES GERCKENS
Director01/04/2021 → 2022 accounts
MARC BREYER
Director14/02/2020 → 2022 accounts
SINOPLE0479.432.396Represented by LAURENT KINET
Managing director14/02/2020 → 2020 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office09/09/2026
    Changement de Siège Social
    PDF
  • Mandates21/05/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates31/05/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates19/04/2021
    DEMISSIONS, NOMINATIONS
    PDF
  • Other20/02/2020
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings6 filings
Mandates
PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT
PIERRE LAFLEUR
JACQUES GERCKENS
SINOPLE
MARC BREYER
2020202120222023202420252026
PHARMAEXPRESS
Rue de Mangombroux 161, 4800 Verviers
Director
Director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Rue de l'Avenir 12, 4890 Thimister-ClermontCurrent
CBE
Rue de Mangombroux 161, 4800 Verviers
accounts 2021 → 2025
Accounts 2025 · 2026-00094506

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
PHARMAEXPRESSCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00094506

Events

  1. 2025
    Annual accounts 2025162,6 k €↓
  2. 2024
    Annual accounts 2024315,7 k €↑
  3. 2023
    Annual accounts 2023-120,9 k €↓
  4. 2022
    Annual accounts 2022-56,5 k €↑
  5. 2021
    Annual accounts 2021-173,6 k €↓
  6. 2020
    Annual accounts 2020-51,1 k €
  7. 18/02/2020
    IncorporationPrivate limited company